Clinical trial
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or…
NCT00057863 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00057863 |
|---|---|
| Title | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer |
| Official title | A Phase II Study of Oxaliplatin in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Cervical Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel, Oxaliplatin |
| Enrollment | 35 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Apr 9, 2003 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: